Femtobiomed Inc.

A327610

KR7327610002

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
8,260 ^KRW	-0.60%		-5.92%	+48.56%

Apr. 23	Femtobiomed Inc. announced that it has received KRW 2.999996625 billion in funding from Korea Investment Partners Co. Ltd.	CI
Mar. 25	Femtobiomed Inc. announced that it expects to receive KRW 2.999996625 billion in funding from Korea Investment Partners Co. Ltd.	CI

Femtobiomed Inc. announced that it has received KRW 5.9999868 billion in funding

February 25, 2021

On February 26, 2021, Femtobiomed Inc. (XKON:A327610) closed the transaction.

Latest news about Femtobiomed Inc.

Femtobiomed Inc. announced that it has received KRW 2.999996625 billion in funding from Korea Investment Partners Co. Ltd.	Apr. 22	CI
Femtobiomed Inc. announced that it expects to receive KRW 2.999996625 billion in funding from Korea Investment Partners Co. Ltd.	Mar. 24	CI
Femtobiomed Inc. announced that it has received KRW 1.999989234 billion in funding	23-09-14	CI
Femtobiomed Inc. announced that it expects to receive KRW 1.999989234 billion in funding	23-09-06	CI
Femtobiomed Inc. announced that it expects to receive KRW 3.9999675 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm	22-05-11	CI
Femtobiomed Inc. announced that it has received KRW 5.9999868 billion in funding	21-02-25	CI
Femtobiomed Inc. announced that it expects to receive KRW 5.9999868 billion in funding	21-02-09	CI

Femtobiomed Inc. is a Korea-based company principally work on the research and development of natural science and engineering. The Company is engaged in the development and manufacture of anticancer vaccines through its platform called CELLSHOT.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
FEMTOBIOMED INC.	+48.56%	49.89M
IQVIA HOLDINGS INC.	+1.12%	43.84B
MODERNA, INC.	+6.77%	41.68B
LONZA GROUP AG	+45.26%	41.25B
CELLTRION, INC.	-11.96%	27.04B
ICON PUBLIC LIMITED COMPANY	+6.01%	25.53B
ALNYLAM PHARMACEUTICALS, INC.	-24.92%	18.18B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.63%	12.29B
MEDPACE HOLDINGS, INC.	+27.16%	12.29B
UNITED THERAPEUTICS CORPORATION	+7.30%	11.15B

Other Biotechnology & Medical Research

Femtobiomed Inc.

Equities

A327610

KR7327610002

Biotechnology & Medical Research

Femtobiomed Inc. announced that it has received KRW 5.9999868 billion in funding

Latest news about Femtobiomed Inc.

Chart Femtobiomed Inc.

Company Profile

Sector Other Biotechnology & Medical Research